| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |